BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 29649981)

  • 1. In silico cancer research towards 3R.
    Jean-Quartier C; Jeanquartier F; Jurisica I; Holzinger A
    BMC Cancer; 2018 Apr; 18(1):408. PubMed ID: 29649981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.
    Zhang Q; Bhattacharya S; Andersen ME; Conolly RB
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):253-76. PubMed ID: 20574901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico modeling for tumor growth visualization.
    Jeanquartier F; Jean-Quartier C; Cemernek D; Holzinger A
    BMC Syst Biol; 2016 Aug; 10(1):59. PubMed ID: 27503052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico models of cancer.
    Edelman LB; Eddy JA; Price ND
    Wiley Interdiscip Rev Syst Biol Med; 2010; 2(4):438-459. PubMed ID: 20836040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems Biology of Ageing.
    Chandrasegaran S; Scanlan RL; Clark P; Pease L; Wordsworth J; Shanley DP
    Subcell Biochem; 2023; 102():415-424. PubMed ID: 36600142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.
    Berlow NE; Rikhi R; Geltzeiler M; Abraham J; Svalina MN; Davis LE; Wise E; Mancini M; Noujaim J; Mansoor A; Quist MJ; Matlock KL; Goros MW; Hernandez BS; Doung YC; Thway K; Tsukahara T; Nishio J; Huang ET; Airhart S; Bult CJ; Gandour-Edwards R; Maki RG; Jones RL; Michalek JE; Milovancev M; Ghosh S; Pal R; Keller C
    BMC Cancer; 2019 Jun; 19(1):593. PubMed ID: 31208434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation and enforcement of the 3Rs principle in the field of transgenic animals used for scientific purposes. Report and recommendations of the BfR expert workshop, May 18-20, 2009, Berlin, Germany.
    Kretlow A; Butzke D; Goetz ME; Grune B; Halder M; Henkler F; Liebsch M; Nobiling R; Oelgeschlaeger M; Reifenberg K; Schaefer B; Seiler A; Luch A
    ALTEX; 2010; 27(2):117-34. PubMed ID: 21445538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report on EU-USA workshop: how systems biology can advance cancer research (27 October 2008).
    Aebersold R; Auffray C; Baney E; Barillot E; Brazma A; Brett C; Brunak S; Butte A; Califano A; Celis J; Cufer T; Ferrell J; Galas D; Gallahan D; Gatenby R; Goldbeter A; Hace N; Henney A; Hood L; Iyengar R; Jackson V; Kallioniemi O; Klingmüller U; Kolar P; Kolch W; Kyriakopoulou C; Laplace F; Lehrach H; Marcus F; Matrisian L; Nolan G; Pelkmans L; Potti A; Sander C; Seljak M; Singer D; Sorger P; Stunnenberg H; Superti-Furga G; Uhlen M; Vidal M; Weinstein J; Wigle D; Williams M; Wolkenhauer O; Zhivotovsky B; Zinovyev A; Zupan B
    Mol Oncol; 2009 Feb; 3(1):9-17. PubMed ID: 19383362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of Modeling and Simulation Methods in Computational Biology.
    Avramouli A
    Adv Exp Med Biol; 2020; 1194():323-330. PubMed ID: 32468548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gentle introduction to understanding preclinical data for cancer pharmaco-omic modeling.
    Piyawajanusorn C; Nguyen LC; Ghislat G; Ballester PJ
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34368843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Strategies in Assessment of Nanotoxicity: Alternatives to In Vivo Animal Testing.
    Huang HJ; Lee YH; Hsu YH; Liao CT; Lin YF; Chiu HW
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems Biology-Driven Hypotheses Tested In Vivo: The Need to Advancing Molecular Imaging Tools.
    Verma G; Palombo A; Grigioni M; La Monaca M; D'Avenio G
    Methods Mol Biol; 2018; 1702():337-359. PubMed ID: 29119514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SysBioMed report: advancing systems biology for medical applications.
    Wolkenhauer O; Fell D; De Meyts P; Blüthgen N; Herzel H; Le Novère N; Höfer T; Schürrle K; van Leeuwen I
    IET Syst Biol; 2009 May; 3(3):131-6. PubMed ID: 19449974
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.